Influence of handling conditions on the establishment and propagation of head and neck cancer patient derived xenografts

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Stein, Andrew P ^a,b   Saha, Sandeep ^a   Liu, Cheng Z ^a   Hartig, Gregory K ^a   Lambert, Paul F ^b   Kimple, Randall J ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INFILTRATION; CANCER SURGERY; CANCER TRANSPLANTATION; CRYOPRESERVATION; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; KERATINIZATION; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PATIENT DERIVED XENOGRAFT; TIME; TISSUE CHARACTERIZATION; TISSUE PREPARATION; TISSUE PRESERVATION; TISSUE SURVIVAL; TUMOR NECROSIS; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; CANCER GRADING; DISEASE MODEL; HEAD AND NECK TUMOR; PATHOLOGY; SPECIMEN HANDLING; XENOGRAFT;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HEAD AND NECK NEOPLASMS; HETEROGRAFTS; HUMANS; MALE; MICE; NEOPLASM GRADING; SPECIMEN HANDLING; TUMOR BURDEN;

EID: 84903395341     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100995     Document Type: Article

References (39)

1. Kimple RJ, Harari PM, Torres AD, Yang RZ, Soriano BJ, et al. (2013) Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts. Clin Cancer Res 19: 855-864.
2. Rygaard J, Povlsen CO (1969) Heterotransplantation of a human malignant tumour to "Nude" mice. Acta Pathol Microbiol Scand 77: 758-760.
3. Giovanella BC, Stehlin JS Jr, Williams LJ Jr, Lee SS, Shepard RC (1978) Heterotransplantation of human cancers into nude mice: a model system for human cancer chemotherapy. Cancer 42: 2269-2281. (Pubitemid 9125885)
4. Jimeno A, Feldmann G, Suarez-Gauthier A, Rasheed Z, Solomon A, et al. (2009) A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. Mol Cancer Ther 8: 310-314.
5. Garrido-Laguna I, Uson M, Rajeshkumar NV, Tan AC, de Oliveira E, et al. (2011) Tumor engraftment in nude mice and enrichment in stroma- related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer. Clin Cancer Res 17: 5793-5800.
6. Rubio-Viqueira B, Jimeno A, Cusatis G, Zhang X, Iacobuzio-Donahue C, et al. (2006) An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res 12: 4652-4661. (Pubitemid 44297818)
7. DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, et al. (2011) Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med 17: 1514-1520.
8. Dong X, Guan J, English JC, Flint J, Yee J, et al. (2010) Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clin Cancer Res 16: 1442-1451.
9. Daniel VC, Marchionni L, Hierman JS, Rhodes JT, Devereux WL, et al. (2009) A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res 69: 3364-3373.
10. Sivanand S, Pena-Llopis S, Zhao H, Kucejova B, Spence P, et al. (2012) A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma. Sci Transl Med 4: 137ra175.
11. Keysar SB, Astling DP, Anderson RT, Vogler BW, Bowles DW, et al. (2013) A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins. Mol Oncol 7: 776-790.
12. Sorio C, Bonora A, Orlandini S, Moore PS, Capelli P, et al. (2001) Successful xenografting of cryopreserved primary pancreatic cancers. Virchows Arch 438: 154-158. (Pubitemid 32186583)
13. Hidalgo M, Bruckheimer E, Rajeshkumar NV, Garrido-Laguna I, De Oliveira E, et al. (2011) A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer. Mol Cancer Ther 10: 1311-1316.
14. Zatterstrom UK, Braakhuis BJ, Wennerberg J, van Dongen GA, Attewell R, et al. (1992) Growth of xenografted squamous cell carcinoma of the head and neck-possible correlation with patient survival. APMIS 100: 976-980. (Pubitemid 23012560)
15. Chen J, Milo GE, Shuler CF, Schuller DE (1996) Xenograft growth and histodifferentiation of squamous cell carcinomas of the pharynx and larynx. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81: 197-202. (Pubitemid 126812915)
16. Wennerberg J, Trope C, Biorklund A (1983) Heterotransplantation of human head and neck tumours into nude mice. Acta Otolaryngol 95: 183-190. (Pubitemid 13206215)
17. Tentler JJ, Tan AC, Weekes CD, Jimeno A, Leong S, et al. (2012) Patient-derived tumour xenografts as models for oncology drug development. Nat Rev Clin Oncol 9: 338-350.
18. Sealed Envelope: Power (Sample Size) Calculators.
19. Masters JR (2002) HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer 2: 315-319.
20. Boyd MR (1997) The NCI In Vitro Anticancer Drug Discovery Screen. Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval: 20.
21. Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, et al. (2001) Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 84: 1424-1431. (Pubitemid 32522115)
22. Borrell B (2010) How accurate are cancer cell lines? Nature 463: 858.
23. Gillet JP, Calcagno AM, Varma S, Marino M, Green LJ, et al. (2011) Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance. Proc Natl Acad Sci U S A 108: 18708-18713.
24. Uva P, Lahm A, Sbardellati A, Grigoriadis A, Tutt A, et al. (2010) Comparative Membranome expression analysis in primary tumors and derived cell lines. PLoS One 5: e11742.
25. Ertel A, Verghese A, Byers SW, Ochs M, Tozeren A (2006) Pathway-specific differences between tumor cell lines and normal and tumor tissue cells. Mol Cancer 5: 55.
26. Feng XD, Huang SG, Shou JY, Liao BR, Yingling JM, et al. (2007) Analysis of pathway activity in primary tumors and NCI60 cell lines using gene expression profiling data. Genomics Proteomics Bioinformatics 5: 15-24. (Pubitemid 46899643)
27. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, et al. (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24: 227-235. (Pubitemid 30132189)
28. Wang H, Huang S, Shou J, Su EW, Onyia JE, et al. (2006) Comparative analysis and integrative classification of NCI60 cell lines and primary tumors using gene expression profiling data. BMC Genomics 7: 166.
29. Collins MA, Bednar F, Zhang Y, Brisset JC, Galban S, et al. (2012) Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. J Clin Invest 122: 639-653.
30. Westphalen CB, Olive KP (2012) Genetically engineered mouse models of pancreatic cancer. Cancer J 18: 502-510.
31. Yoon SS, Stangenberg L, Lee YJ, Rothrock C, Dreyfuss JM, et al. (2009) Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 74: 1207-1216.
32. Zhou Y, Rideout WM, 3rd, Zi T, Bressel A, Reddypalli S, et al. (2010) Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas. Nat Biotechnol 28: 71-78.
33. Strati K, Pitot HC, Lambert PF (2006) Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model. Proc Natl Acad Sci U S A 103: 14152-14157. (Pubitemid 44452995)
34. Park JW, Shin MK, Pitot HC, Lambert PF (2013) High incidence of HPV-associated head and neck cancers in FA deficient mice is associated with E7's induction of DNA damage through its inactivation of pocket proteins. PLoS One 8: e75056.
35. Brake T, Lambert PF (2005) Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc Natl Acad Sci U S A 102: 2490-2495. (Pubitemid 40279404)
36. Choyce A, Yong M, Narayan S, Mattarollo SR, Liem A, et al. (2013) Expression of a single, viral oncoprotein in skin epithelium is sufficient to recruit lymphocytes. PLoS One 8: e57798.
37. Qiu C, Wu H, He H, Qiu W (2003) A cervical lymph node metastatic model of human tongue carcinoma: Serial and orthotopic transplantation of histologically intact patient specimens in nude mice. J Oral Maxillofac Surg 61: 696-700. (Pubitemid 36644859)
38. Jarzabek MA, Huszthy PC, Skaftnesmo KO, McCormack E, Dicker P, et al. (2013) In vivo bioluminescence imaging validation of a human biopsy-derived orthotopic mouse model of glioblastoma multiforme. Mol Imaging 12: 161-172.
39. Sano D, Myers JN (2009) Xenograft models of head and neck cancers. Head Neck Oncol 1: 32.